Good point sputnick. Apparently Bressington spoke at HGR's...

Good point sputnick. Apparently Bressington spoke at HGR's recent corporate presentation.

While this home testing market has potential, it is currently quite small compared to the workplace and schools testing markets.

Its part of the over the counter (OTC) market. HGR's 13 June corporate presentation puts it in perspective. That presentation indicated that 27,000 pharmacies (worldwide or US - not clear) sell an average of 12 tests per calendar month - ie 3.8m tests pa. That is only 3% of the US workplace testing market of 133m tests pa. So a useful market, but not critical.

Exciting couple of weeks for HGR coming up. The MD went to the US 3 weeks ago with several deals at an 'advance stage' of negotiation. He went over to work with the new and experienced COO to complete these negotiations - presumably covering Mexico, US, China, Russia and perhaps others. The MD is due back in around a week.

I reckon some news on some of these negotiations, before the AGM at the end of next week would be a good bet.